HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Germany Reverse-Switches Phytohustil, Expands Iberogast

Executive Summary

Bayer Vital is taking the unusual step to reverse-switch its Phytohustil range of herbal cough medicines in Germany, to strengthen the role of pharmacy in ensuring consumers access the right products for their needs. The company is also launching a new celandine-free addition to its embattled Iberograst brand of herbal gastrointestinal medicines. 

You may also be interested in...



In Bayer North America Executive Moves, Consumer Chief Lockwood-Taylor Adds US Business Top Post

Lockwood-Taylor will start post on 1 August while continuing as North America consumer health chief. Also in North America, Dave Tomasi adds chief commercial officer post and Jeff Jarrett moves to chief marketing officer.

Bayer To Settle Monsanto Litigation, Remains Prepared To Invest For Growth

The health care and crop science conglomerate will pay up to $10.9bn to resolve most Roundup claims, but still has capital to do bolt-on deals like last year’s BlueRock cell therapy buy.

Bayer’s Supplement Sales Leap By A Third On COVID Boost

Bayer posts double-digit rise in Q1 Consumer Health sales off the back of unprecedented demand for its dietary supplements in the middle of the global coronavrius pandemic. 

Related Content

Topics

UsernamePublicRestriction

Register

LL1122113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel